Abstract:Fibrotic valvular heart disease (VHD) has been observed in patients with Parkinson's disease treated with dopamine receptor agonists such as pergolide and cabergoline. 5-Hydroxytryptamine2B receptor (5-HT2BR) agonism is the most likely cause, but other 5-HT receptors may also play a role in VHD. We aimed at characterizing the molecular fragment of cabergoline responsible for agonism at 5-HT2BR and 5-HT2AR. Cabergoline with an allyl substituent at N(6) behaved as a potent 5-HT2BR full agonist in relaxation of porcine pulmonary arteries and as a weaker 5-HT2AR partial agonist in contraction of coronary arteries. The same was true for cabergoline derivatives with cyclopropylmethyl, propyl, or ethyl at N(6). However, agonism was converted into antagonism, when the N(6) substituent was methyl. 6-Methylcabergoline retained agonism compared with cabergoline at human dopamine D2LONG and human dopamine D2SHORT receptors as determined by guanosine 5′-O-(3-[35S]thio)triphosphate binding. In porcine aortic valve cusps, 5-HT-induced contractions were inhibited by ketanserin (5-HT2A/2CR antagonist) but not by N-(1-methyl-1H-5-indolyl)-N′-(3-methyl-5-isothiazolyl)urea (SB204741) (5-HT2BR antagonist). In porcine valvular interstitial cells, cabergoline-induced activation of extracellular signal-regulated kinase (ERK) 1/2, an initiator of cellular proliferation and activity, was blocked by (R)-(+)-4-(1-hydroxy-1-(2,3-dimethoxyphenyl)methy1)-N-2-(4-fluorophenylethyl)piperidine (MDL100907) (5-HT2AR antagonist) and N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)-1,1′-biphenyl-4-carboxamide (GR127935) (5-HT1BR antagonist), whereas the stimulatory effect on [3H]proline and [3H]glucosamine incorporations (indices of extracellular matrix collagen and glycosaminoglycan) was blocked by MDL100907. We conclude that the bulky N(6) substituent of cabergoline is responsible for 5-HT2AR and 5-HT2BR agonism. The increased ERK1/2 phosphorylation and production of extracellular matrix by cabergoline are mediated by 5-HT2ARs. However, the moderate potency of cabergoline at native 5-HT2ARs suggests that these are not the preferential target in VHD in vivo.

Polyethylenimine-Modified Membranes for CO2 Capture and in Situ Hydrogenation

Polyethylenimine-Grafted Hkust-Type Mof/Poiyhipe Porous Composites (Pei@Pgd-H) As Highly Efficient Co(2 )Adsorbents

Preparation of amino-functionalized polyethylene-silica composite membrane and FDH immobilization

Carbon Dioxide Capture with Polyethylenimine-Functionalized Industrial-Grade Multiwalled Carbon Nanotubes

Facile surface amination strategy of PIM-1 based membranes for efficient CO 2 capture

Polyethylenimine-impregnated resin for high CO2 adsorption: an efficient adsorbent for CO2 capture from simulated flue gas and ambient air.

Novel aminated F-Ce nanosheet mixed matrix membranes with controllable channels for CO 2 capture

Post‐synthesis Amination of Polymer of Intrinsic Microporosity Membranes for CO2 Separation

Hydrophobic Modification of Polyetherimide Hollow Fiber Membrane Contactor by 2-(Perfluoroalkyl) Ethanol Coating for Carbon Dioxide Absorption

Selective Separation of Low Concentration CO2 Using Hydrogel Immobilized CA Enzyme Based Hollow Fiber Membrane Reactors

Tuning the Acidity and Textural Properties for Enhanced Economical CO2 Capture in Polyethyleneimine (PEI) Supported Adsorbents

Contrast echocardiography in acute myocardial ischemia: I. In vivo determination of total left ventricular "area at risk".

Adsorptive Removal of Carbon Dioxide Using Polyethyleneimine Supported on Propanesulfonic-Acid-Functionalized Mesoporous SBA-15

Capturing Carbon Dioxide from Air Using a Fixed Carrier Facilitated Transport Membrane

Discovering Inherent Characteristics of Polyethylenimine-Functionalized Porous Materials for CO2 Capture

Physicochemical synergistic adsorption of CO2 by PEI‐impregnated hierarchical porous polymers

Co-grafting of polyethyleneimine on facilely synthesized mesoporous P(DVB-D) for highly effective CO 2 adsorption and enhanced oxidation resistance

The Bulky N(6) Substituent of Cabergoline Is Responsible for Agonism of This Drug at 5-Hydroxytryptamine (5-HT)2A and 5-HT2B Receptors and Thus Is a Determinant of Valvular Heart Disease

Interfacial Control of Polyhipe with Nano-Tio2 Particles and Polyethylenimine Toward Actual Application in CO2 Capture

Atom-level interaction design between amines and support for achieving efficient and stable CO2 capture

Swallowtail porphyrins: synthesis, characterization and incorporation into porphyrin dyads.